Drug Approval | November 24, 2021
U.S. FDA approves first treatment for drug-resistant post-transplant infection
The approval is for Cytomegalovirus, a type of Herpes virus
The approval is for Cytomegalovirus, a type of Herpes virus
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
Subscribe To Our Newsletter & Stay Updated
